Skip to main content

VRAX · Virax Biolabs Group Ltd · Debt

Track VRAX — free
$2.06 -0.34 (-14.17%)
Market Cap
$1.91M
Shares
796,988
Volume · Oct 6 310.74K Avg daily vol (3M) 1.74M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Lease liabilities 2026-03-31 USD 385,910 20-F filed 2026-07-06
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current lease liabilities
USD 81,102
Noncurrent lease liabilities
USD 304,808
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1885827 CUSIP G9495L133 Visit website Investor relations